CAMBRIDGE, Mass.--(BUSINESS WIRE)--Goldfinch Bio, a clinical stage biotechnology company focused on discovering and developing precision medicines for the treatment of kidney diseases, today announced ...

FSGS is a disease that damages the glomeruli, which are the filtering units inside the kidneys that clean the blood. It leads to scarring, or sclerosis, in the kidneys. FSGS only occurs in small ...

Our understanding of the pathogenesis of most primary glomerular diseases, including IgA nephropathy, membranous nephropathy and focal segmental glomerulosclerosis, is limited. Advances in molecular ...

Focal segmental glomerulosclerosis (FSGS) is a rare form of kidney inflammation (glomerulonephritis) in which the glomeruli become increasingly scarred (sclerotic), leading to progressive loss of ...

Steroid-resistant nephrotic syndrome (SRNS) represents glomerular disease resulting from a number of different etiologies leading to focal segmental glomerulosclerosis (FSGS). Recently, many genes ...

New York, USA, Aug. 19, 2025 (GLOBE NEWSWIRE) -- Focal Segmental Glomerulosclerosis Clinical Trial Pipeline Analysis Demonstrates 12+ Key Companies at the Horizon Expected to Transform the Treatment ...

There is no cure for focal segmental glomerulosclerosis (FSGS), but the proper care can keep your kidneys healthy for years. FSGS treatment that includes an early diagnosis, personalized treatment, ...

Focal segmental glomerulosclerosis (FSGS) is a syndrome for which there is no reliable treatment, in part because of a poor understanding of its pathophysiology. However, recent research has ...

A number of new diagnostic and therapeutic tools have emerged in the field of glomerular diseases. Editor’s note: The article is a preview of a course being offered on April 2 during the National ...

Zane was just 15 months old when his parents noticed something wasn’t right. His eyes, legs and belly were very swollen. At first, it seemed like allergies. As soon as the pediatrician saw Zane, he ...